
Results
3008
Most Popular Stocks on the market
3008 companies
Eli Lilly
Market Cap: US$1.0t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,131.42
7D
4.5%
1Y
46.2%
Johnson & Johnson
Market Cap: US$560.3b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$232.77
7D
4.1%
1Y
50.0%
AbbVie
Market Cap: US$401.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$227.23
7D
6.7%
1Y
20.1%
Roche Holding
Market Cap: CHF 260.8b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 327.10
7D
3.1%
1Y
22.0%
Merck
Market Cap: US$298.3b
Operates as a healthcare company worldwide.
MRK
US$120.79
7D
4.9%
1Y
52.3%
AstraZeneca
Market Cap: UK£214.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£138.58
7D
3.2%
1Y
28.6%
Novartis
Market Cap: CHF 216.0b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 117.98
7D
3.6%
1Y
21.5%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 283.85
7D
-0.4%
1Y
-42.1%
Amgen
Market Cap: US$188.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$349.58
7D
6.2%
1Y
20.6%
Thermo Fisher Scientific
Market Cap: US$175.7b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$472.80
7D
-4.3%
1Y
15.7%
Gilead Sciences
Market Cap: US$160.4b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$129.16
7D
-1.5%
1Y
14.3%
Pfizer
Market Cap: US$148.4b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$26.04
7D
1.6%
1Y
8.6%
Danaher
Market Cap: US$130.4b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$184.30
7D
2.5%
1Y
-7.5%
Bristol-Myers Squibb
Market Cap: US$116.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$57.27
7D
4.2%
1Y
16.9%
Vertex Pharmaceuticals
Market Cap: US$113.4b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
US$446.83
7D
1.9%
1Y
0.2%
Sanofi
Market Cap: €93.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€77.95
7D
5.1%
1Y
-10.9%
GSK
Market Cap: UK£77.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.38
7D
5.2%
1Y
28.4%
Chugai Pharmaceutical
Market Cap: JP¥12.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,493.00
7D
-2.2%
1Y
-3.5%
Merck KGaA
Market Cap: €59.5b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€136.85
7D
4.6%
1Y
18.1%
Regeneron Pharmaceuticals
Market Cap: US$64.7b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$635.45
7D
5.8%
1Y
22.8%
UCB
Market Cap: €49.7b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€261.00
7D
2.7%
1Y
62.6%
argenx
Market Cap: €47.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€766.00
7D
6.7%
1Y
49.2%
Takeda Pharmaceutical
Market Cap: JP¥7.8t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,047.00
7D
3.4%
1Y
16.4%
Galderma Group
Market Cap: CHF 37.9b
Operates as a dermatology company worldwide.
GALD
CHF 161.50
7D
-1.5%
1Y
39.3%
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥311.7b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥45.94
7D
-6.6%
1Y
-15.5%
Sun Pharmaceutical Industries
Market Cap: ₹4.3t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
SUNPHARMA
₹1,788.80
7D
-0.4%
1Y
5.6%
WuXi AppTec
Market Cap: CN¥293.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥96.00
7D
-4.0%
1Y
48.1%
Lonza Group
Market Cap: CHF 33.9b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 485.60
7D
-2.1%
1Y
-15.3%
Bayer
Market Cap: €35.5b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€36.16
7D
2.9%
1Y
36.5%
Alnylam Pharmaceuticals
Market Cap: US$40.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$303.05
7D
2.5%
1Y
-0.3%
Haleon
Market Cap: UK£29.9b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.37
7D
3.1%
1Y
-15.3%
Teva Pharmaceutical Industries
Market Cap: US$39.8b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$34.19
7D
-1.3%
1Y
89.2%
Samsung BiologicsLtd
Market Cap: ₩62.0t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,237,000.00
7D
-10.2%
1Y
-22.1%
Agilent Technologies
Market Cap: US$38.3b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$135.44
7D
-0.4%
1Y
16.0%
Waters
Market Cap: US$35.9b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$365.36
7D
-3.4%
1Y
4.9%
Sandoz Group
Market Cap: CHF 27.9b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 64.40
7D
0.3%
1Y
46.3%